封面
市場調查報告書
商品編碼
1944477

全球酵素免疫分析法市場:依產品類型、檢體、應用、最終用戶、國家及地區分類-產業分析、市場規模、佔有率及2025年至2032年未來預測

Enzyme Immunoassay Market, By Product Type, By Specimen, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年,酵素免疫分析法市場規模將達到 178.5009 億美元,並預計從 2025 年到 2032 年將以 3.87% 的複合年成長率成長。

酵素免疫分析法(EIA) 是一種生化分析技術,它利用抗原-抗體反應的高特異性來檢測和定量特定物質,例如抗原、抗體、荷爾蒙、蛋白質和藥物。在該方法中,酵素與抗體或抗原化學連接,並作為訊號產生器。當目標分子與相應的抗體結合時,連接的酵素會催化與添加的基材反應,產生可測量的訊號(通常是顏色變化、螢光或發光)。

酵素免疫分析法市場動態

慢性病和感染疾病的增加,以及診斷基礎設施的不斷完善,預計將推動市場需求。

愛滋病、肝炎、結核病和新發病毒感染疾病等感染疾病的日益流行是推動酵素免疫分析法市場成長的主要因素。酵素免疫分析法因其高準確度、高特異性和成本效益,被廣泛應用於早期診斷、大規模篩檢和確診檢測。同時,心血管疾病、癌症、自體免疫疾病和糖尿病等慢性疾病的日益普遍,進一步推動了可靠且高效診斷解決方案的需求。酵素免疫分析法對於識別疾病特異性生物標記、荷爾蒙和抗體至關重要,從而能夠實現及時診斷和疾病進展的持續監測。隨著全球醫療保健系統越來越重視預防保健、早期檢測和改善患者預後,基於酵素免疫分析的診斷檢測在全球各地的醫院、臨床檢查室和診斷中心的應用正在穩步擴展。

酵素免疫分析法平台技術的持續進步,包括改進的ELISA試劑盒、先進的自動化技術、多重檢測能力以及更高效的酵素和基材的開發,正顯著推動市場擴張。自動化和半自動化的EIA系統尤其受到現代臨床檢查室的青睞,因為它們能夠提高檢測效率、最大限度地減少人為誤差並實現高通量分析。此外,在政府扶持政策和私部門投資不斷成長的推動下,新興經濟體醫療保健和診斷基礎設施的快速發展,也擴大了先進診斷解決方案的普及範圍。酵素免疫分析法在藥物研發、疫苗開發和臨床試驗的應用日益廣泛,也推動了市場需求。技術創新與基礎設施建設的結合,正在加速酵素免疫分析法在全球的應用,無論其應用領域是臨床、研究或工業。

酵素免疫分析法市場:細分分析

全球酵素免疫分析法市場按產品類型、檢體、應用、最終用戶和地區進行細分。

根據檢體,檢測可分為五大類:血液、尿液、唾液和其他。血液樣本因其診斷可靠性高、臨床應用廣泛,在檢體類別中佔據主導地位。血液檢體中含有高濃度的生物標記物,例如抗原、抗體、荷爾蒙和蛋白質,這使得酵素免疫分析法)能夠展現出極佳的靈敏度和特異性。血液檢測在醫院、診斷檢查室和研究實驗室的廣泛應用,進一步提升了該類別的收入佔有率。

根據應用領域,市場可分為六大類:感染疾病、心臟病、腫瘤、自體免疫疾病、治療藥物監測及其他。受全球感染疾病感染疾病將佔據最大的市場佔有率。愛滋病、B肝、C肝、結核病、流感以及其他病毒和細菌性行為感染等疾病仍然是重大的公共衛生挑戰,尤其是在人口稠密和發展中地區。這種持續的疾病負擔催生了對準確、快速且經濟高效的診斷方法的強烈需求。

酵素免疫分析法市場—區域分析

全球酵素免疫分析法市場按地區分類為北美、拉丁美洲、歐洲、亞太以及中東和非洲。北美佔據酵素免疫分析法市場的大部分佔有率,這主要得益於其先進的檢查室基礎設施、高額的醫療保健支出、自動化免疫檢測技術的早期應用以及大型診斷公司的強大影響力。歐洲緊隨其後,這主要得益於其健全的公共醫療保健體系、廣泛的常規篩檢計畫以及對感染疾病和慢性病早期檢測的日益重視。亞太地區是成長最快的市場,這主要得益於醫療保健服務覆蓋範圍的擴大、疾病負擔的加重、人們對早期診斷檢測意識提升以及政府和私營企業(尤其是在中國和印度等國家)對檢查室基礎設施的大量投資。拉丁美洲市場也呈現穩定成長態勢,這主要歸功於醫療保健基礎設施的持續改善和診斷檢測量的不斷增加。

目錄

第1章酵素免疫分析法市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章酵素免疫分析法的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章酵素免疫分析法市場:產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望:概覽
  • 管理體制分析

第5章酵素免疫分析法市場:地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章酵素免疫分析法市場概況

  • 酵素免疫分析法市場佔有率分析(2024 年)
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章酵素免疫分析法市場:依產品類型分類

  • 概述
    • 細分市場佔有率分析:依產品類型
    • 試劑和試劑盒
    • 裝置
    • 軟體和服務

第8章 依檢體的酵素免疫分析法市場

  • 概述
    • 細分市場佔有率分析:按檢體
    • 尿
    • 唾液
    • 其他

第9章酵素免疫分析法市場:依應用分類

  • 概述
    • 細分市場佔有率分析:按應用
    • 感染疾病
    • 心臟病學
    • 腫瘤學
    • 自體免疫疾病
    • 治療藥物監測
    • 其他

第10章 依最終用戶分類的酵素免疫分析法市場

  • 概述
    • 細分市場佔有率分析:依最終用戶分類
    • 醫院
    • 診斷檢查室
    • 製藥和生物技術公司
    • 學術研究
    • 其他

第11章酵素免疫分析法市場(按地區分類)

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲(MEA)
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析—酵素免疫分析法產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Siemens Healthineers
    • Danaher Corporation
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • bioMerieux SA
    • QuidelOrtho Corporation
    • Becton, Dickinson and Company
    • Sysmex Corporation
    • PerkinElmer(Revvity)
    • Agilent Technologies
    • Merck KGaA
    • DiaSorin SpA
    • Randox Laboratories
    • VION Biosciences
    • Others

第13章:分析師視角360度分析

簡介目錄
Product Code: ANV6012

Enzyme Immunoassay Market size was valued at USD 17,850.09 Million in 2024, expanding to a CAGR of 3.87% from 2025 to 2032.

Enzyme Immunoassay (EIA) is a biochemical analytical technique used to detect and quantify specific substances such as antigens, antibodies, hormones, proteins, or drugs by exploiting the high specificity of antigen antibody interactions. In this method, an enzyme is chemically linked to an antibody or antigen and acts as a signal generator. When the target molecule binds to its corresponding antibody, the attached enzyme catalyzes a reaction with an added substrate, producing a measurable signal, usually a color change, fluorescence, or luminescence.

Enzyme Immunoassay Market- Market Dynamics

Increasing prevalence of chronic, infectious diseases and expansion of diagnostic infrastructure are expected to propel market demand

The rising incidence of infectious diseases such as HIV, hepatitis, tuberculosis, and newly emerging viral infections is a key factor driving growth in the enzyme immunoassay market. Enzyme immunoassays are extensively used for early diagnosis, large-scale screening, and confirmatory testing because they offer high accuracy, strong specificity, and cost-effective performance. At the same time, the increasing prevalence of chronic diseases including cardiovascular diseases, cancer, autoimmune conditions, and diabetes has intensified the need for dependable and efficient diagnostic solutions. Enzyme immunoassays are essential for identifying disease-specific biomarkers, hormones, and antibodies, enabling timely diagnosis and continuous monitoring of disease progression. With healthcare systems worldwide placing greater emphasis on preventive care, early detection, and improved patient outcomes, the use of EIA-based diagnostic tests is steadily expanding across hospitals, clinical laboratories, and diagnostic centers across the globe.

Ongoing technological advancements in enzyme immunoassay platforms such as improved ELISA kits, greater automation, multiplex testing capabilities, and the development of more efficient enzymes and substrates, are significantly contributing to market expansion. Automated and semi-automated EIA systems enhance testing efficiency, minimize manual errors, and enable high-throughput analysis, making them especially appealing to modern clinical laboratories. In addition, the rapid development of healthcare and diagnostic infrastructure in emerging economies, driven by supportive government policies and increased private-sector investment, has broadened access to advanced diagnostic solutions. The expanding application of enzyme immunoassays in pharmaceutical research, vaccine development, and clinical trial activities is also boosting market demand. Collectively, technological innovation and infrastructure growth are accelerating the widespread adoption of enzyme immunoassays across clinical, research, and industrial settings worldwide.

Enzyme Immunoassay Market- Segmentation Analysis:

The Global Enzyme Immunoassay Market is segmented on the basis of Product Type, Specimen, Application, End User, and Region.

The market is divided into five categories based on Specimen: blood, urine, saliva, and others. Blood segment in the specimen is primarily held major share because of its high diagnostic reliability and broad clinical applicability. Blood-based samples provide higher concentrations of biomarkers such as antigens, antibodies, hormones, and proteins, enabling enzyme immunoassays to deliver superior sensitivity and specificity. The widespread use of blood tests in hospitals, diagnostic laboratories, and research settings further boosts this segment's revenue share.

The market is divided into six categories based on Application: infectious diseases, cardiology, oncology, autoimmune disorders, therapeutic drug monitoring, and others. The infectious diseases segment held the majority market share in 2024, driven by the consistently high prevalence and incidence of infectious diseases across the globe. Conditions such as HIV/AIDS, hepatitis B and C, tuberculosis, influenza, and other viral and bacterial infections continue to pose significant public health challenges, particularly in densely populated and developing regions. This sustained disease burden has created strong demand for accurate, rapid, and cost-effective diagnostic methods.

Enzyme Immunoassay Market- Geographical Insights

Across the globe, the Enzyme Immunoassay market is split in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America accounts for the substantial share of the enzyme immunoassay market, driven by its advanced laboratory infrastructure, substantial healthcare expenditure, early adoption of automated immunoassay technologies, and the strong presence of major diagnostic companies. Followed by Europe which is supported by robust public healthcare systems, widespread routine screening programs, and increasing emphasis on early detection of infectious and chronic diseases. The Asia Pacific region represents the fastest-growing market, propelled by expanding access to healthcare services, a rising burden of diseases, greater awareness of early diagnostic testing, and significant investments in laboratory infrastructure by both governments and private players, particularly in countries such as China and India. Latin America is experiencing steady growth due to ongoing improvements in healthcare infrastructure and increasing volumes of diagnostic testing.

Italy Enzyme Immunoassay Market- Key Insights

China stands out as a major country in the Asia Pacific region and rapidly expanding country-level market within the enzyme immunoassay (EIA) sector. Growth is largely fueled by its vast population, the rising incidence of infectious and chronic diseases, and a growing need for timely and accurate diagnostic solutions. Government-led efforts to enhance public healthcare systems, broaden disease screening initiatives, and upgrade laboratory infrastructure have significantly accelerated the uptake of enzyme immunoassays in hospitals and diagnostic centers. Additionally, the strong expansion of China's biotechnology and pharmaceutical industries has increased the use of EIAs in areas such as drug discovery, vaccine development, and clinical research. Greater awareness of preventive healthcare, along with increasing adoption of automated and high-throughput immunoassay technologies, continues to drive steady and long-term growth of the EIA market in China.

Enzyme Immunoassay Market- Competitive Landscape:

The enzyme immunoassay (EIA) market is characterized by intense competition, with a mix of global healthcare conglomerates and specialized diagnostic companies competing to strengthen their market positions. Leading players such as Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, bioMerieux SA, and QuidelOrtho maintain strong competitiveness through extensive product portfolios, advanced immunoassay platforms, and well-established global distribution networks. These companies focus heavily on continuous innovation, offering automated and high-throughput enzyme immunoassay systems that improve laboratory efficiency, accuracy, and turnaround times. Significant investments in research and development enable them to regularly introduce new and improved assay kits targeting infectious diseases, chronic conditions, and specialized diagnostic applications.

Recent Developments:

In 2025, Revvity Inc. introduced the IDS i20, a fully automated chemiluminescence immunoassay solution, empowering multi-specialty testing on a single system which enhance workflow efficiency for clinical labs.

In February 2025, VION Biosciences completed the acquisition of BioAssay Systems, a company known for its expertise in high-throughput enzyme immunoassay technologies. This strategic move enhanced VION's footprint in the diagnostics and life sciences tools.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENZYME IMMUNOASSAY MARKET KEY PLAYERS

  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • PerkinElmer (Revvity)
  • Agilent Technologies
  • Merck KGaA
  • DiaSorin S.p.A.
  • Randox Laboratories
  • VION Biosciences
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Reagents & Kits
  • Instruments
  • Software & Services

GLOBAL ENZYME IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2019-2032

  • Blood
  • Urine
  • Saliva
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Infectious diseases
  • Cardiology
  • Oncology
  • Autoimmune disorders
  • Therapeutic drug monitoring
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotech Companies
  • Academic Research
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Enzyme Immunoassay Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Enzyme Immunoassay Market Snippet by Product Type
    • 2.1.2. Enzyme Immunoassay Market Snippet by Specimen
    • 2.1.3. Enzyme Immunoassay Market Snippet by Application
    • 2.1.4. Enzyme Immunoassay Market Snippet by End User
    • 2.1.5. Enzyme Immunoassay Market Snippet by Country
    • 2.1.6. Enzyme Immunoassay Market Snippet by Region
  • 2.2. Competitive Insights

3. Enzyme Immunoassay Key Market Trends

  • 3.1. Enzyme Immunoassay Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Enzyme Immunoassay Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Enzyme Immunoassay Market Opportunities
  • 3.4. Enzyme Immunoassay Market Future Trends

4. Enzyme Immunoassay Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Enzyme Immunoassay Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Enzyme Immunoassay Market Landscape

  • 6.1. Enzyme Immunoassay Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Enzyme Immunoassay Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Kits
    • 7.1.3. Instruments
    • 7.1.4. Software & Services

8. Enzyme Immunoassay Market - By Specimen

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
    • 8.1.2. Blood
    • 8.1.3. Urine
    • 8.1.4. Saliva
    • 8.1.5. Others

9. Enzyme Immunoassay Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Infectious diseases
    • 9.1.3. Cardiology
    • 9.1.4. Oncology
    • 9.1.5. Autoimmune disorders
    • 9.1.6. Therapeutic drug monitoring
    • 9.1.7. Others

10. Enzyme Immunoassay Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Pharmaceutical & Biotech Companies
    • 10.1.5. Academic Research
    • 10.1.6. Others

11. Enzyme Immunoassay Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Enzyme Immunoassay Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Enzyme Immunoassay Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Enzyme Immunoassay Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Enzyme Immunoassay Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Enzyme Immunoassay Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Enzyme Immunoassay Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Siemens Healthineers
    • 12.2.2. Danaher Corporation
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. F. Hoffmann-La Roche AG
    • 12.2.5. Abbott Laboratories
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. bioMerieux SA
    • 12.2.8. QuidelOrtho Corporation
    • 12.2.9. Becton, Dickinson and Company
    • 12.2.10. Sysmex Corporation
    • 12.2.11. PerkinElmer (Revvity)
    • 12.2.12. Agilent Technologies
    • 12.2.13. Merck KGaA
    • 12.2.14. DiaSorin S.p.A.
    • 12.2.15. Randox Laboratories
    • 12.2.16. VION Biosciences
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us